Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs. Our mission is to identify, develop, and bring to market high-impact therapies that have the potential to improve the lives of patients with prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.
Kriya Therapeutics Address
1100 Island Drive Redwood City, CA United States
Kriya Therapeutics Email
Past Companies
Kriya TherapeuticsVice President, Research and Development, Neurology
Arvelle TherapeuticsSenior Director Nonclinical Research and Development
Axovant SciencesSenior Director Nonclinical, Axovant Sciences